Prospective Cohort for the Evaluation of Biomarkers Following HCT (BMT CTN 1202)

Mount Sinai Medical Center, New York

Memorial Sloan-Kettering Cancer Center, New York

Roswell Park, Buffalo

University of Pennsylvania Cancer Center, Philadelphia

Nemours/Alfred I. duPont Hospital for Children, Wilmington

Children's National Medical Center, Washington D.C.

Johns Hopkins, Baltimore

Virginia Commonwealth University, Richmond

University of North Carolina Hospital at Chapel Hill, Chapel Hill

Duke University, Durham

Children's Healthcare of Atlanta, Atlanta

Emory University, Atlanta

BMT at Northside Hospital, Atlanta

University of Florida College of Medicine (Shands), Gainesville

H. Lee Moffitt Cancer Center, Tampa

All Children's Hospital, St. Petersburg

Ohio State/Arthur G. James Cancer Hospital, Columbus

University Hospitals of Cleveland/Case Western, Cleveland

Cleveland Clinic Foundation, Cleveland

University of Minnesota, Minneapolis

Mayo Clinic - Rochester, Rochester

Ann and Robert H. Lurie Children's Hospital, Chicago

Washington University/Barnes Jewish Hospital, St Louis

Washington University/St. Louis Children's Hospital, St Louis

University of Kansas Hospital, Kansas City

University of Nebraska Medical Center, Omaha

Children's Medical Center of Dallas, Dallas

Cook Children's Hospital, Fort Worth

Baylor College of Medicine/The Methodist Hospital, Houston

University of Texas/MD Anderson CRC, Houston

Texas Transplant Institute, San Antonio

Utah BMT/Primary Children's Medical Center, Salt Lake City

Phoenix Children's Hospital, Phoenix

City of Hope National Medical Center, Duarte

University of CA, SF, San Francisco

Stanford Hospitals and Clinics, Stanford

Children's Hospital at Oakland, Oakland

Oregon Health & Science University, Portland

Fred Hutchinson Cancer Research Center, Seattle

DFCI/Brigham & Women's, Boston

University of Michigan Medical Center, Ann Arbor

Hackensack University Medical Center, Hackensack